cjc-1295 + ipamorelin peptide Blend 10mg Canada — Janoshik Tested CJC-1295-5mg/Ipamorelin-5mg | Peptides World

Exactly what I needed. COA verification process was easy and professional.

2 Endocrine / GHRH pharmacologyModified GRF 1-29 (CJC-1295) as a short-acting GHRH analog and its pulsatile GH effect

Other side effects Additional reported side effects include: Joint pain and water retention Muscle and joint aches Headaches and nausea Receptor desensitization with prolonged use Potential suppression of natural GH and IGF-1 production Who should avoid IGF-1 LR3 Certain groups should not use IGF-1 LR3: Anyone with active cancer or tumor history Those with severe insulin resistance or diabetes Pregnant or nursing women Anyone under 25 whose growth plates haven't closed Those with existing hormonal imbalances IGF-1 LR3 is not FDA-approved for general medical use and remains primarily a research compound

Pituitary wellness, people

CJC-1295 and Ipamorelin are not FDA-approved

Ipamorelin pushes the second